Dousing yourself or someone else in ice-cold water started on social media eight years ago. The ALS Association received $115 million in donations.
The nonprofit poured $2.2 million into a clinical trial for a new promising drug to treat the disease.
ALS, also known as Lou Gehrig’s disease, causes muscles to weaken and eventually impacts the ability to talk, swallow, move and even breathe.Earlier this year, an FDA advisory panel voted not to approve the drug. But on Thursday, the full FDA gave the new oral medication the green light. The drug works as a stand-alone therapy or when added to other treatments. The outcome shows it can slow down the disease.
"This drug has shown that it's effective and safe, and those are two really important things. And what it's shown to do is slow the progression of ALS and extend life," said Calaneet Balas, President and CEO of the ALS Association.The next step includes making sure patients living with ALS have access to the new drug.that I have read and agree
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA approves ALS drug whose study was partly funded by Ice Bucket Challenge | CNNThe US FDA has approved a new ALS drug that was backed by patients and advocacy groups. Its study had been partly funded by the viral Ice Bucket Challenge.
Leer más »
Much-debated drug from Amylyx for Lou Gehrig’s disease wins FDA approvalA much-debated drug for Lou Gehrig’s disease won U.S. approval on Thursday from the Food and Drug Administration.
Leer más »
Despite Questionable Data, Drug for Lou Gehrig’s Disease Wins FDA ApprovalA much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Leer más »
The FDA Has Approved A New Drug To Fight ALS And It Was Partly Funded By The Ice Bucket ChallengeThe Ice Bucket Challenge raised $115 million and part of that money helped fund the study for a new drug that was just approved by the FDA.
Leer más »
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner.Late Thursday, the Food and Drug Administration approved the use of Relyvrio to treat amyotrophic lateral sclerosis, more commonly known as ALS. Rosenblum said he's thrilled by the decision and immediately requested a prescription for it.
Leer más »